Adam S. Chervin

1.2k total citations
28 papers, 951 citations indexed

About

Adam S. Chervin is a scholar working on Immunology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Adam S. Chervin has authored 28 papers receiving a total of 951 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 17 papers in Oncology and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Adam S. Chervin's work include CAR-T cell therapy research (15 papers), Immune Cell Function and Interaction (14 papers) and T-cell and B-cell Immunology (13 papers). Adam S. Chervin is often cited by papers focused on CAR-T cell therapy research (15 papers), Immune Cell Function and Interaction (14 papers) and T-cell and B-cell Immunology (13 papers). Adam S. Chervin collaborates with scholars based in United States, Netherlands and Italy. Adam S. Chervin's co-authors include David M. Kranz, Jennifer D. Stone, Ann Marie Craig, Daniel W. Allison, Vladimir I. Gelfand, David H. Aggen, Boris Engels, Jing An, Howard S. Ducoff and Ziwei Huang and has published in prestigious journals such as Journal of Neuroscience, Blood and The Journal of Immunology.

In The Last Decade

Adam S. Chervin

25 papers receiving 936 citations

Peers

Countries citing papers authored by Adam S. Chervin

Since Specialization

Citations

This map shows the geographic impact of Adam S. Chervin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam S. Chervin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam S. Chervin more than expected).

Fields of papers citing papers by Adam S. Chervin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam S. Chervin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam S. Chervin. The network helps show where Adam S. Chervin may publish in the future.

Co-authorship network of co-authors of Adam S. Chervin

This figure shows the co-authorship network connecting the top 25 collaborators of Adam S. Chervin. A scholar is included among the top collaborators of Adam S. Chervin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam S. Chervin. Adam S. Chervin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	ABBV-303 Is an NK-cell Engager Specific for c-Met–Expressing Tumors 2025 ·Cancer Research ·Jennifer D. Stone, Kamonwan Fish, Devika Ashok, Lisa A. McKay, Saeed Salehin Akhand, Enrico L. DiGiammarino, H. David Inzunza, Joann P. Palma, Cormac Cosgrove, Paul A. Ellis, (unknown), (unknown), Adam S. Chervin, (unknown), Tamar Uziel, Edward B. Reilly	0
2	ABBV-184: A Novel Survivin-specific TCR/CD3 Bispecific T-cell Engager is Active against Both Solid Tumor and Hematologic Malignancies 2023 ·Molecular Cancer Therapeutics ·Adam S. Chervin, Jennifer D. Stone, Iwona Konieczna, (unknown), Ningyan Wang, Dipica Haribhai, (unknown), (unknown), Luis E. Rodrı́guez, Gail Bukofzer, Paul A. Ellis, Cormac Cosgrove, Claudie Hecquet, (unknown), Joann P. Palma, Edward B. Reilly	7
3	Studies of the TLR4-associated protein MD-2 using yeast-display and mutational analyses 2015 ·Molecular Immunology ·(unknown), Adam S. Chervin, Diana Rose E. Rañoa, (unknown), Richard I. Tapping, David M. Kranz	2
4	A Multiplex Assay for Detection of Staphylococcal and Streptococcal Exotoxins 2015 ·PLoS ONE ·Preeti Sharma, Ningyan Wang, Adam S. Chervin, Cheryl L. Quinn, Jennifer D. Stone, David M. Kranz	5
5	A novel T cell receptor single-chain signaling complex mediates antigen-specific T cell activity and tumor control 2014 ·Cancer Immunology Immunotherapy ·Jennifer D. Stone, Daniel T. Harris, (unknown), Adam S. Chervin, David H. Aggen, Edward J. Roy, David M. Kranz	34
6	Design of T-cell receptor libraries with diverse binding properties to examine adoptive T-cell responses 2012 ·Gene Therapy ·Adam S. Chervin, Jennifer D. Stone, (unknown), Boris Engels, Hans Schreiber, Edward J. Roy, David M. Kranz	18
7	Design and characterization of a protein superagonist of IL‐15 fused with IL‐15Rα and a high‐affinity T cell receptor 2012 ·Biotechnology Progress ·Jennifer D. Stone, Adam S. Chervin, Hans Schreiber, David M. Kranz	6
8	T Cell Receptor Engineering 2012 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Jennifer D. Stone, Adam S. Chervin, David H. Aggen, David M. Kranz	18
9	MHC-class I-restricted CD4 T cells: a nanomolar affinity TCR has improved anti-tumor efficacy in vivo compared to the micromolar wild-type TCR 2012 ·Cancer Immunology Immunotherapy ·(unknown), Jennifer D. Stone, Adam S. Chervin, Boris Engels, Hans Schreiber, Edward J. Roy, David M. Kranz	21
10	Long-term Persistence of CD4+ but Rapid Disappearance of CD8+ T Cells Expressing an MHC Class I-restricted TCR of Nanomolar Affinity 2012 ·Molecular Therapy ·Boris Engels, Adam S. Chervin, Andrea J. Sant, David M. Kranz, Hans Schreiber	36
11	Interaction of Streptavidin-Based Peptide-MHC Oligomers (Tetramers) with Cell-Surface T Cell Receptors 2011 ·DSpace@MIT (Massachusetts Institute of Technology) ·Jennifer D. Stone, Maxim N. Artyomov, Adam S. Chervin, Arup K. Chakraborty, Herman N. Eisen, David M. Kranz	1
12	Single-chain VαVβ T-cell receptors function without mispairing with endogenous TCR chains 2011 ·Gene Therapy ·David H. Aggen, Adam S. Chervin, Thomas M. Schmitt, Boris Engels, Jennifer D. Stone, Sarah A. Richman, Kurt H. Piepenbrink, Brian M. Baker, P D Greenberg, (unknown), David M. Kranz	42
13	Identification and engineering of human variable regions that allow expression of stable single-chain T cell receptors 2010 ·Protein Engineering Design and Selection ·David H. Aggen, Adam S. Chervin, Francis Insaidoo, Kurt H. Piepenbrink, Brian M. Baker, David M. Kranz	37
14	The Impact of TCR-Binding Properties and Antigen Presentation Format on T Cell Responsiveness 2009 ·The Journal of Immunology ·Adam S. Chervin, Jennifer D. Stone, Phillip D. Holler, Ailin Bai, Jianzhu Chen, Herman N. Eisen, David M. Kranz	60
15	Cutting Edge: Inhibitory Effects of CD4 and CD8 on T Cell Activation Induced by High-Affinity Noncognate Ligands 2009 ·The Journal of Immunology ·Adam S. Chervin, Jennifer D. Stone, Natalie A. Bowerman, David M. Kranz	10
16	Engineering higher affinity T cell receptors using a T cell display system 2008 ·Journal of Immunological Methods ·Adam S. Chervin, David H. Aggen, (unknown), David M. Kranz	49
17	T‐cell receptor binding affinities and kinetics: impact on T‐cell activity and specificity 2008 ·Immunology ·Jennifer D. Stone, Adam S. Chervin, David M. Kranz	277
18	Oligomerization of BH4-truncated Bcl-xL in solution 2007 ·Biochemical and Biophysical Research Communications ·Youli Wang, Rong Cao, Dongxiang Liu, Adam S. Chervin, Jian Yuan, Jing An, Ziwei Huang	4
19	Overcoming the radioresistance of prostate cancer cells with a novel Bcl-2 inhibitor 2006 ·Oncogene ·Jing An, Adam S. Chervin, Anmin Nie, Howard S. Ducoff, Ziwei Huang	84
20	Postsynaptic Scaffolds of Excitatory and Inhibitory Synapses in Hippocampal Neurons: Maintenance of Core Components Independent of Actin Filaments and Microtubules 2000 ·Journal of Neuroscience ·Daniel W. Allison, Adam S. Chervin, Vladimir I. Gelfand, Ann Marie Craig	193

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact